Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 25;21(4):1564–1575. doi: 10.1111/ajt.16316

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. American Journal of Transplantation published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Time to first infection within 1‐year posttransplant, by intensity of desensitization. Compared to recipients who received no desensitization (i.e., CLDKT), ILDKT recipients had a faster time to infection. At 1 month, the post–KT incidence was 19.2%, 25.5%, 28.4%, and 45.9% for recipients who received none, low, moderate, and high levels of desensitization, respectively (P < .001). At 6 months, the post–KT incidence was 37.2%, 43.0%, 54.6%, and 70.1% for recipients who received none, low, moderate, and high levels of desensitization (P < .001). At 1 year, the post–KT incidence was 50.1%, 49.8%, 66.0%, and 73.5% for recipients who received none, low, moderate, and high levels of desensitization (P < .001)